Pipeline
A diversified gerotherapeutic pipeline.
Program
Therapeutic Area
Discovery
In Vitro PoC
In Vivo PoC
Lead Optimization
IND-Enabling
NL-101
Cognitive decline & neuroinflammation
Small-molecule gerotherapeutic program for brain-aging biology and cognitive resilience.
NL-102
Cancer therapy-induced senescence
Program targeting persistent senescent-like tumor cell states linked to resistance and relapse.
NL-103
Fibrosis & chronic inflammation
Early program focused on aging-associated tissue remodeling and inflammatory dysfunction.
NL-104
Skin aging & tissue resilience
Exploratory program aimed at repair capacity, tissue quality, and age-related structural decline.
Near-term goal
Convert early gerotherapeutic candidates into defined preclinical programs with clear functional endpoints.
IP discipline
Protect chemical identities, use claims, and development strategy before public or confidential disclosure.
Partnership logic
Build a pipeline that can support licensing, strategic collaboration, or future venture formation.